相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience
Sarah E. S. Leary et al.
CANCER (2013)
Investigation of the Effect of Mistletoe (Viscum album L.) Extract Iscador on the Proliferation and Apoptosis of Murine Thymocytes
Tibor Hajtò et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2012)
Effects of Viscum album L. extract and quercetin on methotrexate-induced cyto-genotoxicity in mouse bone-marrow cells
Zulal Atli Sekeroglu et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2012)
A randomized study with adjuvant mistletoe versus oral Etoposide on post relapse disease-free survival in osteosarcoma patients
Alessandra Longhi et al.
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE (2009)
Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group
Paul A. Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cancer and the immune system: an overview - Introduction
G. E. Blair et al.
ONCOGENE (2008)
Post operative infection and increased survival in osteosarcoma patients: Are they associated?
L. M. Jeys et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Resection of recurrent pulmonary metastases in patients with osteosarcoma
A Briccoli et al.
CANCER (2005)
Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy
G Bacci et al.
ACTA ONCOLOGICA (2005)
Treatment with oral etoposide for childhood recurrent ependymomas
A Sandri et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Interferon-α as the only adjuvant treatment in high-grade osteosarcoma:: Long term results of the Karolinska Hospital series
CR Müller et al.
ACTA ONCOLOGICA (2005)
The Viscum album extract Iscador P does not cause an autocrine interleukin-6 loop in B-non-Hodgkin's lymphoma cell lines
F Hugo et al.
ONKOLOGIE (2005)
Oral etoposide for recurrent/progressive sarcomas of childhood
R Kebudi et al.
PEDIATRIC BLOOD & CANCER (2004)
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors:: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group
P Schöffski et al.
ANNALS OF ONCOLOGY (2004)
Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity
J Tabiasco et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
High-dose chemotherapy in the treatment of relapsed osteosarcoma: An Italian sarcoma group study
F Fagioli et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)